Effects of Oral Anticoagulant and Aspirin Use on Ability of Fecal Immunochemical Tests to Detect Advanced Neoplasia

Colorectal cancer (CRC) has a significant impact on public health owing to its high incidence, morbidity, and mortality.1 It is the third most common cancer in men and second in women, and in most countries the second leading cause of cancer-related death.1,2 The early detection and removal of precursor cancer lesions decreases CRC incidence and mortality. CRC screening has, therefore, been implemented in various countries worldwide.3 The selected modality varies per country or region and differs from primary colonoscopy, sigmoidoscopy to noninvasive testing, in particular by means of a fecal immunochemical test (FIT).

Source: Gastroenterology - March 25, 2019 Category: Gastroenterology Authors: Manon C.W. Spaander, Ernst J. Kuipers Tags: Editorial Source Type: research